Your browser doesn't support javascript.
loading
BCR-ABL1 molecular remission after 90Y-epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B-ALL: proof of principle.
Chevallier, Patrice; Bodet-Milin, Caroline; Robillard, Nelly; Eugene, Thomas; Menard, Audrey; Le Houerou, Claire; Guillaume, Thierry; Delaunay, Jacques; Escoffre-Barbe, Martine; Wegener, William A; Goldenberg, David M; Kraeber-Bodéré, Francoise.
Affiliation
  • Chevallier P; Centre Hospitalier et Universitaire (CHU) de Nantes, Hématologie Clinique, Centre d'Investigation Clinique en Cancérologie (CI2C), Université de Nantes and INSERM CRNCA UMR 892, Nantes, France.
Eur J Haematol ; 91(6): 552-6, 2013 Dec.
Article in En | MEDLINE | ID: mdl-23927500
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Yttrium Radioisotopes / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Fusion Proteins, bcr-abl / Radioimmunotherapy / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Yttrium Radioisotopes / Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Fusion Proteins, bcr-abl / Radioimmunotherapy / Antibodies, Monoclonal, Humanized Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2013 Document type: Article Affiliation country: Country of publication: